These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20040344)

  • 1. Metabolic syndrome in mental illness: evidence and way out.
    Saddichha S
    Int J Clin Pharmacol Ther; 2010 Jan; 48(1):84-6. PubMed ID: 20040344
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic effects associated with atypical antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2004; 40(2):70-2. PubMed ID: 15323415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness.
    Kouidrat Y; Amad A; De Hert M
    Curr Pharm Des; 2015; 21(23):3317-24. PubMed ID: 26088113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why all GPs should be bothered about Billy.
    Graham CC; Chitnis AJ; Turner P; Mitchell AJ; Hardy S; Shiers D
    Br J Gen Pract; 2014 Jan; 64(618):15. PubMed ID: 24567556
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic Side Effects in Patients Using Atypical Antipsychotic Medications During Hospitalization.
    Dikeç G; Arabaci LB; Uzunoglu GB; Mizrak SD
    J Psychosoc Nurs Ment Health Serv; 2018 Apr; 56(4):28-37. PubMed ID: 29328360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?
    Correll CU
    J Clin Psychiatry; 2005 Oct; 66(10):1331-2. PubMed ID: 16259549
    [No Abstract]   [Full Text] [Related]  

  • 8. Who is responsible for metabolic screening for mental health clients taking antipsychotic medications?
    Ward T; Wynaden D; Heslop K
    Int J Ment Health Nurs; 2018 Feb; 27(1):196-203. PubMed ID: 28093900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-metabolic risk in individuals prescribed long-acting injectable antipsychotic medication.
    Morell R; Curtis J; Watkins A; Poole J; Fibbins H; Rossimel E; Gerrard M; White A; Teasdale S; Ward PB; Lappin J
    Psychiatry Res; 2019 Nov; 281():112606. PubMed ID: 31629301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in patients with schizophrenia: CATIE results.
    Narasimhan M; Masand P
    Curr Psychiatry Rep; 2006 Jun; 8(3):213-4. PubMed ID: 19817071
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic screening for patients with second-generation antipsychotic medication: A population-based study from 2004 to 2016.
    Lee EHM; Hui CLM; Law EYL; Chan PY; Chang WC; Chan SKW; Chen EYH
    Schizophr Res; 2018 Jul; 197():618-619. PubMed ID: 29477247
    [No Abstract]   [Full Text] [Related]  

  • 12. Bipolar disorder, schizophrenia, and metabolic syndrome.
    Bartoli F; Carrà G; Crocamo C; Carretta D; Clerici M
    Am J Psychiatry; 2013 Aug; 170(8):927-8. PubMed ID: 23903338
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of the use of atypical antipsychotics in metabolic syndrome.
    Doménech-Matamoros P
    Rev Esp Sanid Penit; 2020; 22(2):80-86. PubMed ID: 32697278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study.
    Hammoudeh S; Ghuloum S; Mahfoud Z; Yehya A; Abdulhakam A; Al-Mujalli A; Al-Zirie M; Abdel Rahman MO; Godwin A; Younes N; Hani Y; Mook-Kanamori D; Mook-Kanamori M; El Sherbiny R; Al-Amin H
    BMC Psychiatry; 2018 Mar; 18(1):81. PubMed ID: 29587717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to Bartoli et al.
    Vancampfort D; Mitchell AJ; Correll CU; Sienaert P; De Hert M
    Am J Psychiatry; 2013 Aug; 170(8):928-9. PubMed ID: 23903339
    [No Abstract]   [Full Text] [Related]  

  • 16. Second-generation antipsychotics and the metabolic syndrome.
    Masand PS; Mago R
    Curr Psychiatry Rep; 2005 Jun; 7(3):153-4. PubMed ID: 15935125
    [No Abstract]   [Full Text] [Related]  

  • 17. Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record.
    Lui K; Randhawa G; Totten V; Smith AE; Raese J
    Prim Care Companion CNS Disord; 2016; 18(1):. PubMed ID: 27247842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic screen and intervene: improving mental health inpatient metabolic monitoring.
    Viglione L; Short BL
    Australas Psychiatry; 2021 Jun; 29(3):289-293. PubMed ID: 32615781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot lifestyle education intervention for patients with severe mental illness during the inpatient stay.
    Wu C; Chiang M; Natarajan R; Fusaro-Davis M; Cimpeanu C; Liu M; Harrington A; Fan X
    Asian J Psychiatr; 2019 Feb; 40():15-17. PubMed ID: 30673623
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between antipsychotic-induced metabolic side-effects and clinical improvement: a review on the evidence for metabolic threshold: author's response.
    Sharma E; Rao NP; Venkatasubramanian G
    Asian J Psychiatr; 2014 Oct; 11():76. PubMed ID: 25453703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.